This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
In this note, the authors describe the implementation of the “hypothetical monopolist SSNIP test” for market definition in the context of merger cases where firms produce multiple differentiated products.
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...
FTCWatch recently conducted an in-depth interview with Vice President Nate Goldstein, exploring his transition from a distinguished 23-year tenure at the...
CRA is a proud sponsor of the conference. Laurent Flochel moderates the opening discussion on “Mergers in the EU & US: What has changed?” For more information...
CRA is a proud sponsor of this event featuring a full-day program of insightful presentations and discussions on intellectual property valuation, damages...
